This summary was created by AI, based on 1 opinions in the last 12 months.
Experts agree that the Manulife Multifactor Canadian SMID Cap Index ETF is a good option to pair with a large-cap ETF, as it provides exposure to small- and mid-cap companies. This diversification can complement a total stock market index, which already includes a significant percentage of small- and mid-cap companies. Overall, the ETF offers a well-rounded investment opportunity for those seeking exposure to smaller Canadian companies.
Manulife Multifactor Canadian SMID Cap Index ETF is a Canadian stock, trading under the symbol MCSM-T on the Toronto Stock Exchange (MCSM-CT). It is usually referred to as TSX:MCSM or MCSM-T
In the last year, 1 stock analyst published opinions about MCSM-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Manulife Multifactor Canadian SMID Cap Index ETF.
Manulife Multifactor Canadian SMID Cap Index ETF was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Manulife Multifactor Canadian SMID Cap Index ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Manulife Multifactor Canadian SMID Cap Index ETF published on Stockchase.
On 2024-12-11, Manulife Multifactor Canadian SMID Cap Index ETF (MCSM-T) stock closed at a price of $43.16.
Good to pair with a large-cap ETF. If you already use a total stock market index, already about 30% is made up of thousands of small- and mid-cap companies.